A report of novel inactivating missense mutations of BRCA1 detected in patients with acute myeloid leukemia

Key Points

• The aim is to characterize the mutational spectrum of BRCA1 in acute myeloid leukemia patients.
• Analysis of BRCA1 mutations in acute myeloid leukemia patients.
• Identification of missense and novel pathogenic mutations.
• Implications for diagnostic and therapeutic approaches.
• Identification of unique missense mutations in BRCA1.
• Discovery of novel pathogenic mutations relevant to acute myeloid leukemia.
• Findings suggest targeting these mutations for treatment strategies.